See more : Magnachip Semiconductor Corporation (MX) Income Statement Analysis – Financial Results
Complete financial analysis of PT Sepatu Bata Tbk. (BATA.JK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PT Sepatu Bata Tbk., a leading company in the Apparel – Footwear & Accessories industry within the Consumer Cyclical sector.
- Hyundai Bioscience Co., Ltd. (048410.KQ) Income Statement Analysis – Financial Results
- Avalo Therapeutics, Inc. (AVTX) Income Statement Analysis – Financial Results
- ikuyo Co.,Ltd. (7273.T) Income Statement Analysis – Financial Results
- Youcare Pharmaceutical Group Co., Ltd. (688658.SS) Income Statement Analysis – Financial Results
- Amelco Corporation (AMLC) Income Statement Analysis – Financial Results
PT Sepatu Bata Tbk. (BATA.JK)
About PT Sepatu Bata Tbk.
PT Sepatu Bata Tbk. engages in the manufacture and sale of footwear products in Indonesia. The company offers leather footwear, canvas built-up footwear, casual and sports shoes, injection molded sandals/slippers, and industrial safety footwear. It is also involved in the import, export, and distribution of footwear. The company offers its products through stores, as well as online. It serves retail dealers and wholesalers. The company was founded in 1931 and is headquartered in South Jakarta, Indonesia. PT Sepatu Bata Tbk. operates as a subsidiary of Bafin (Nederland) B.V.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 609.61B | 643.45B | 438.48B | 459.58B | 931.27B | 992.70B | 974.54B | 999.80B | 1,028.85B | 1,008.73B | 902.46B | 751.45B | 678.59B | 644.19B | 598.47B |
Cost of Revenue | 481.83B | 383.43B | 242.72B | 361.65B | 502.69B | 516.93B | 526.71B | 568.35B | 622.10B | 558.23B | 539.45B | 400.96B | 369.61B | 338.00B | 322.78B |
Gross Profit | 127.78B | 260.02B | 195.77B | 97.93B | 428.58B | 475.77B | 447.82B | 431.45B | 406.75B | 450.50B | 363.01B | 350.49B | 308.98B | 306.19B | 275.68B |
Gross Profit Ratio | 20.96% | 40.41% | 44.65% | 21.31% | 46.02% | 47.93% | 45.95% | 43.15% | 39.53% | 44.66% | 40.22% | 46.64% | 45.53% | 47.53% | 46.07% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 76.56B | 78.80B | 51.67B | 44.63B | 88.43B | 85.13B | 75.09B | 73.78B | 75.20B | 76.97B | 66.54B | 54.18B | 78.63B | 78.99B | 75.27B |
Selling & Marketing | 86.84B | 81.56B | 50.13B | 61.10B | 65.27B | 74.42B | 74.25B | 68.96B | 70.65B | 67.52B | 62.95B | 51.39B | 149.22B | 140.07B | 125.45B |
SG&A | 235.02B | 160.36B | 101.79B | 105.73B | 153.70B | 159.55B | 149.34B | 142.73B | 145.84B | 144.48B | 129.49B | 105.57B | 227.85B | 219.06B | 200.73B |
Other Expenses | 37.63B | 157.33B | 165.68B | 180.38B | 233.50B | 230.27B | 221.00B | -1.87B | -6.36B | 368.93M | 680.41M | -478.73M | -1.48B | 558.56M | 457.71M |
Operating Expenses | 376.74B | 317.69B | 267.47B | 286.11B | 387.20B | 381.73B | 362.48B | 361.51B | 370.18B | 345.51B | 292.18B | 248.11B | 227.85B | 219.06B | 200.73B |
Cost & Expenses | 757.89B | 701.12B | 510.19B | 647.76B | 889.89B | 898.65B | 889.19B | 929.86B | 992.28B | 903.73B | 831.63B | 649.07B | 597.46B | 557.06B | 523.51B |
Interest Income | 119.54M | 62.31M | 234.59M | 654.77M | 140.75M | 168.36M | 380.71M | 230.38M | 115.69M | 87.09M | 122.98M | 124.10M | 153.03M | 140.19M | 182.81M |
Interest Expense | 16.29B | 7.55B | 5.98B | 13.37B | 2.36B | 2.83B | 1.36B | 981.40M | 6.21B | 4.37B | 1.76B | 1.14B | 2.55B | 4.39B | 4.98B |
Depreciation & Amortization | 101.27B | 102.34B | 110.78B | 120.99B | 33.85B | 32.02B | 30.13B | 33.34B | 24.88B | 29.94B | 18.78B | 16.18B | -409.22M | 1.25B | 1.51B |
EBITDA | -46.91B | 43.90B | 53.78B | -90.68B | 72.07B | 121.70B | 110.33B | 99.63B | 181.35B | 138.76B | 88.37B | 121.34B | 101.48B | 87.13B | 76.66B |
EBITDA Ratio | -7.70% | 6.28% | 8.17% | -15.61% | 7.45% | 12.10% | 11.13% | 9.34% | 5.10% | 13.08% | 9.66% | 15.50% | 11.90% | 13.72% | 12.78% |
Operating Income | -148.28B | -59.76B | -72.54B | -188.17B | 38.11B | 95.54B | 80.50B | 66.05B | 154.90B | 103.21B | 65.39B | 100.16B | 81.13B | 87.13B | 74.96B |
Operating Income Ratio | -24.32% | -9.29% | -16.54% | -40.94% | 4.09% | 9.62% | 8.26% | 6.61% | 15.06% | 10.23% | 7.25% | 13.33% | 11.96% | 13.53% | 12.53% |
Total Other Income/Expenses | -13.87B | -7.50B | -5.79B | -12.85B | -2.25B | -2.70B | -979.73M | -751.02M | -12.45B | -4.29B | -1.63B | -1.02B | -2.50B | -2.56B | -3.28B |
Income Before Tax | -162.15B | -68.14B | -64.00B | -225.04B | 35.86B | 92.88B | 79.52B | 65.30B | 142.44B | 98.93B | 63.76B | 99.15B | 78.63B | 84.57B | 71.68B |
Income Before Tax Ratio | -26.60% | -10.59% | -14.60% | -48.97% | 3.85% | 9.36% | 8.16% | 6.53% | 13.84% | 9.81% | 7.06% | 13.19% | 11.59% | 13.13% | 11.98% |
Income Tax Expense | 28.41B | 37.98B | -12.77B | -47.28B | 12.42B | 24.93B | 25.87B | 23.07B | 12.92B | 28.14B | 19.38B | 29.80B | 22.02B | 23.59B | 18.70B |
Net Income | -190.29B | -106.12B | -51.23B | -177.76B | 23.44B | 67.94B | 53.65B | 42.23B | 129.52B | 70.78B | 44.37B | 69.34B | 56.62B | 60.98B | 52.98B |
Net Income Ratio | -31.21% | -16.49% | -11.68% | -38.68% | 2.52% | 6.84% | 5.51% | 4.22% | 12.59% | 7.02% | 4.92% | 9.23% | 8.34% | 9.47% | 8.85% |
EPS | -146.37 | -81.63 | -39.41 | -136.74 | 18.03 | 52.27 | 41.27 | 32.49 | 99.63 | 54.80 | 34.13 | 53.34 | 43.55 | 46.90 | 40.75 |
EPS Diluted | -146.37 | -81.63 | -39.41 | -136.74 | 18.03 | 52.27 | 41.27 | 32.49 | 99.63 | 54.80 | 34.13 | 53.34 | 43.55 | 46.90 | 40.75 |
Weighted Avg Shares Out | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B |
Weighted Avg Shares Out (Dil) | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B | 1.30B |
Source: https://incomestatements.info
Category: Stock Reports